BioScrip completes offering
By HME News Staff
Updated Wed June 22, 2016
DENVER - BioScrip has completed a public offering of common stock, netting approximately $83.15 million. The company will use the proceeds to fund the cash portion of its acquisition of HS Infusion Holdings; repay a portion of outstanding borrowings from its revolving credit facility; and for general corporate purposes, according to a press release. BioScrip announced earlier this month that it would acquire the Hammonton, N.J.-based Home Solutions for $85 million—$80 million of it in cash.
Comments